These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

595 related items for PubMed ID: 27998978

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Tyrosine-phosphorylated SOCS3 negatively regulates cellular transformation mediated by the myeloproliferative neoplasm-associated JAK2 V617F mutant.
    Funakoshi-Tago M, Tsuruya R, Ueda F, Ishihara A, Kasahara T, Tamura H, Tago K.
    Cytokine; 2019 Nov; 123():154753. PubMed ID: 31255914
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Akt activation through the phosphorylation of erythropoietin receptor at tyrosine 479 is required for myeloproliferative disorder-associated JAK2 V617F mutant-induced cellular transformation.
    Kamishimoto J, Tago K, Kasahara T, Funakoshi-Tago M.
    Cell Signal; 2011 May; 23(5):849-56. PubMed ID: 21255641
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Critical role of FANCC in JAK2 V617F mutant-induced resistance to DNA cross-linking drugs.
    Ueda F, Sumi K, Tago K, Kasahara T, Funakoshi-Tago M.
    Cell Signal; 2013 Nov; 25(11):2115-24. PubMed ID: 23838005
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.
    Arcasoy MO, Harris KW, Forget BG.
    Exp Hematol; 1999 Jan; 27(1):63-74. PubMed ID: 9923445
    [Abstract] [Full Text] [Related]

  • 13. HLA-G turns off erythropoietin receptor signaling through JAK2 and JAK2 V617F dephosphorylation: clinical relevance in polycythemia vera.
    Menier C, Guillard C, Cassinat B, Carosella ED, Rouas-Freiss N.
    Leukemia; 2008 Mar; 22(3):578-84. PubMed ID: 18059484
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The multi-site docking protein Gab1 is constitutively phosphorylated independent from its recruitment to the plasma membrane in Jak2-V617F-positive cells and mediates proliferation of human erythroleukaemia cells.
    Bongartz H, Hessenkemper W, Müller C, Fensky M, Fritsch J, Mandel K, Behrmann I, Haan C, Fischer T, Feller SM, Schaper F.
    Cell Signal; 2017 Jul; 35():37-47. PubMed ID: 28365441
    [Abstract] [Full Text] [Related]

  • 16. Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoietin receptor in vivo.
    Miura O, Nakamura N, Quelle FW, Witthuhn BA, Ihle JN, Aoki N.
    Blood; 1994 Sep 01; 84(5):1501-7. PubMed ID: 8068943
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The myeloproliferative disorder-associated JAK2 V617F mutant escapes negative regulation by suppressor of cytokine signaling 3.
    Hookham MB, Elliott J, Suessmuth Y, Staerk J, Ward AC, Vainchenker W, Percy MJ, McMullin MF, Constantinescu SN, Johnston JA.
    Blood; 2007 Jun 01; 109(11):4924-9. PubMed ID: 17317861
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dimerization by a cytokine receptor is necessary for constitutive activation of JAK2V617F.
    Lu X, Huang LJ, Lodish HF.
    J Biol Chem; 2008 Feb 29; 283(9):5258-66. PubMed ID: 18158285
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.